Cargando…

Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors

BACKGROUND: Handheld devices can automatically give an estimate of refraction. The established method for refraction comparison using spherical equivalent (M) and J0, J45 vector transformations by Bland–Altman analysis is too complex for non-eye doctors involved with vision screening and remote visi...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnold, Robert W, Martin, Samuel J, Beveridge, Joshua R, Arnold, Andrew W, Arnold, Stephanie L, Beveridge, Nathanael R, Smith, Kyle A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415895/
https://www.ncbi.nlm.nih.gov/pubmed/34511869
http://dx.doi.org/10.2147/OPTH.S326680
_version_ 1783748059523448832
author Arnold, Robert W
Martin, Samuel J
Beveridge, Joshua R
Arnold, Andrew W
Arnold, Stephanie L
Beveridge, Nathanael R
Smith, Kyle A
author_facet Arnold, Robert W
Martin, Samuel J
Beveridge, Joshua R
Arnold, Andrew W
Arnold, Stephanie L
Beveridge, Nathanael R
Smith, Kyle A
author_sort Arnold, Robert W
collection PubMed
description BACKGROUND: Handheld devices can automatically give an estimate of refraction. The established method for refraction comparison using spherical equivalent (M) and J0, J45 vector transformations by Bland–Altman analysis is too complex for non-eye doctors involved with vision screening and remote vision clinics. Therefore, a simpler comparison technique was developed. METHODS: Based on the spectacle limit to resolve grade A 1 logMAR, B 3 logMAR and C 6 logMAR blur, J0, J45, and M are combined into the Alaska Blind Child Discovery (ABCD) composite ellipsoid GRADE system. Pediatric eye patients had confirmatory examination after dry refraction with three portable autorefractors: Plusoptix, 2WIN and Retinomax. The refractions were then compared using both Bland–Altman and ABCD composite. Performance to detect AAPOS amblyopia risk factors was also assessed. RESULTS: A total of 202 children, mean age seven years, 28% high spectacle need and 43% AAPOS 2013 amblyopia risk factors showed high correlation with cycloplegic refraction (intraclass correlation 0.49 to 0.90) for sphere, J0 and J45 spectacle components. Plusoptix had more (10%) inconclusives due to patients out-of-range. The Retinomax was unable to screen some younger children and was less reliable for sphere but gave more precise astigmatism estimates. The proportion of autorefractions expected to give GRADE A/B high-need patients acuity improvement to 20/40 would be 41% for Plusoptix, 39% for 2WIN and 65% for Retinomax. Sensitivity/specificity for amblyopia risk factor detection was 80%/83% for Plusoptix, 72%/88% for 2WIN and 84%/73% for Retinomax. CONCLUSION: The simplified spectacle comparison resembled Bland–Altman and could assist lay vision screeners and non-eye doctors attempting remote spectacle donation worldwide.
format Online
Article
Text
id pubmed-8415895
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-84158952021-09-09 Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors Arnold, Robert W Martin, Samuel J Beveridge, Joshua R Arnold, Andrew W Arnold, Stephanie L Beveridge, Nathanael R Smith, Kyle A Clin Ophthalmol Original Research BACKGROUND: Handheld devices can automatically give an estimate of refraction. The established method for refraction comparison using spherical equivalent (M) and J0, J45 vector transformations by Bland–Altman analysis is too complex for non-eye doctors involved with vision screening and remote vision clinics. Therefore, a simpler comparison technique was developed. METHODS: Based on the spectacle limit to resolve grade A 1 logMAR, B 3 logMAR and C 6 logMAR blur, J0, J45, and M are combined into the Alaska Blind Child Discovery (ABCD) composite ellipsoid GRADE system. Pediatric eye patients had confirmatory examination after dry refraction with three portable autorefractors: Plusoptix, 2WIN and Retinomax. The refractions were then compared using both Bland–Altman and ABCD composite. Performance to detect AAPOS amblyopia risk factors was also assessed. RESULTS: A total of 202 children, mean age seven years, 28% high spectacle need and 43% AAPOS 2013 amblyopia risk factors showed high correlation with cycloplegic refraction (intraclass correlation 0.49 to 0.90) for sphere, J0 and J45 spectacle components. Plusoptix had more (10%) inconclusives due to patients out-of-range. The Retinomax was unable to screen some younger children and was less reliable for sphere but gave more precise astigmatism estimates. The proportion of autorefractions expected to give GRADE A/B high-need patients acuity improvement to 20/40 would be 41% for Plusoptix, 39% for 2WIN and 65% for Retinomax. Sensitivity/specificity for amblyopia risk factor detection was 80%/83% for Plusoptix, 72%/88% for 2WIN and 84%/73% for Retinomax. CONCLUSION: The simplified spectacle comparison resembled Bland–Altman and could assist lay vision screeners and non-eye doctors attempting remote spectacle donation worldwide. Dove 2021-08-30 /pmc/articles/PMC8415895/ /pubmed/34511869 http://dx.doi.org/10.2147/OPTH.S326680 Text en © 2021 Arnold et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Arnold, Robert W
Martin, Samuel J
Beveridge, Joshua R
Arnold, Andrew W
Arnold, Stephanie L
Beveridge, Nathanael R
Smith, Kyle A
Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors
title Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors
title_full Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors
title_fullStr Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors
title_full_unstemmed Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors
title_short Ellipsoid Spectacle Comparison of Plusoptix, Retinomax and 2WIN Autorefractors
title_sort ellipsoid spectacle comparison of plusoptix, retinomax and 2win autorefractors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415895/
https://www.ncbi.nlm.nih.gov/pubmed/34511869
http://dx.doi.org/10.2147/OPTH.S326680
work_keys_str_mv AT arnoldrobertw ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors
AT martinsamuelj ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors
AT beveridgejoshuar ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors
AT arnoldandreww ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors
AT arnoldstephaniel ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors
AT beveridgenathanaelr ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors
AT smithkylea ellipsoidspectaclecomparisonofplusoptixretinomaxand2winautorefractors